TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
CLPT

Clearpoint Neuro Inc

Healthcare · Medical Devices

10.50$ -0.1% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CLPT
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 50.7% 55.4% 75.4% 87.5% 84.4% 82.2% 91.7% 84.7% 87.1% 86.3% 94.4% 92.2% 84.8% 85.1% 65.1%
– 4.8% 29.2% 44.7% 69.1% 53.5% 44.8% 66.8% 39.5% 47.8% 68.1% 82.5% 49.8% 54.2% 51.3% 47.0%
– 4.8% 29.2% 44.7% 69.1% 53.5% 44.8% 66.8% 39.5% 47.8% 68.1% 82.5% 67.6% 54.2% 51.3% 47.0%
– 13.3% 8.0% 9.8% 3.5% 12.1% 11.7% 6.8% 15.7% 9.1% 6.4% 3.6% 4.8% 9.2% 12.0% 7.4%
– 32.0% 16.2% 18.8% 14.7% 17.9% 23.9% 16.7% 26.8% 27.2% 11.0% 7.5% 16.8% 18.5% 17.5% 8.6%
– – – – – 4.4% 4.4% 1.9% 4.8% 6.9% 10.3% 4.2% 2.3% – – –
– – – – – – – – – – – – – – 0.0% 7.6%
– – 20.5% – – – – – – – 1.2% 0.4% 1.9% 2.4% 1.2% 14.2%
– 820.8% 203.3% 186.8% 100.7% 119.6% 110.2% 58.1% 80.8% 61.5% 91.9% 25.6% 33.5% 50.4% 35.2% 71.3%
– 481.4% 75.3% 128.2% 36.8% 75.8% 40.8% 31.6% 25.6% 32.1% 10.8% 7.2% 12.2% 17.4% 26.4% 11.0%
– 130.5% 26.2% 55.1% – 41.8% 15.1% 14.4% – 1.0% 1.3% 0.8% 1.0% 1.0% 1.4% 0.7%
– 133.2% 35.3% 17.5% 7.4% 6.9% 20.9% 5.5% 6.4% 8.1% 1.0% 0.7% 0.5% 0.9% 3.4% 1.3%
– – – – – 36.8% 60.7% 21.0% 44.3% 17.4% 72.1% 15.0% 17.8% 23.3% – 50.2%
– -720.8% -103.3% -86.8% -0.7% -19.6% -10.2% 41.9% 19.2% 38.5% 8.1% 74.4% 66.5% 49.6% 64.8% 28.7%
– -1,972.9% -1,179,732.4% -924.1% -577.3% -848.5% -1,268.3% -727.0% -1,364.4% -945.3% -404.9% -204.2% -271.0% -404.2% -488.3% -221.9%
– 13.2% 18.2% 18.2% 11.1% 18.7% 37.2% 55.7% 139.1% 110.3% 53.7% 31.6% 43.6% 57.7% 69.0% 29.0%

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?